Spanish Professional Services Stock News

BME:AMS
BME:AMSHospitality

How AI Partnership With Microsoft And Profit Gains At Amadeus IT Group (BME:AMS) Has Changed Its Investment Story

In the first nine months of 2025, Amadeus IT Group reported revenue growth of 8% and a 9% increase in Adjusted EBIT, while accelerating the rollout of “Agentic AI” and generative AI tools through a partnership with Microsoft to reshape airline retailing and hotel management. This combination of financial progress and AI-driven innovation highlights how Amadeus is using advanced technology partnerships to reinforce its role at the core of global travel infrastructure. With recent share price...
BME:ENG
BME:ENGGas Utilities

Should Enagás’ Pivot to Green Hydrogen and Lower Leverage Require Action From Enagás (BME:ENG) Investors?

Enagás has announced a shift from its traditional role as a gas transmission system operator toward becoming a European leader in green hydrogen infrastructure, supported by a recently strengthened balance sheet through lower net debt. This combination of a hydrogen-focused infrastructure roadmap and reduced leverage signals a material repositioning of Enagás within Europe’s long-term energy transition framework. Next, we will examine how Enagás’s move toward green hydrogen infrastructure...
BME:MAP
BME:MAPInsurance

Does UBS’s Downgrade Recast Mapfre (BME:MAP) As A Value Trap Or An Overlooked Insurer?

In recent days, UBS issued a sell rating on Spanish insurer Mapfre, while assigning a buy rating to its peer Linea Directa. This contrasting analyst stance comes as Mapfre showed relative resilience on a weak Spanish equity market day, drawing extra investor attention. We will now examine how UBS’s bearish stance shapes Mapfre’s investment narrative and what it might mean for investor perception. Uncover the next big thing with financially sound penny stocks that balance risk and reward.What...
BME:LDA
BME:LDAInsurance

3 European Stocks That May Be Trading Below Their Estimated Value By Up To 48.8%

The European market has shown resilience, with the STOXX Europe 600 Index rising 0.77% amid positive economic data and earnings reports, while Germany's economy emerged from a two-year recession with modest growth. In this environment of mixed signals and cautious optimism, identifying stocks that may be trading below their estimated value can offer potential opportunities for investors looking to capitalize on undervaluation in the market.
BME:PHM
BME:PHMBiotechs

Surging Zepzelca Royalties and Profitability Could Be A Game Changer For Pharma Mar (BME:PHM)

Pharma Mar recently reported a sharp improvement in profitability, with EBITDA reaching €25.1 million, as high‑margin license payments and rapidly growing global royalties from its cancer drug Zepzelca, including in the US and China, boosted results. Beyond the headline earnings turnaround, the breadth of Zepzelca uptake across major markets underscores how royalty‑driven income is becoming a more central earnings pillar for Pharma Mar. We’ll now examine how the stronger high‑margin royalty...
BME:PUIG
BME:PUIGPersonal Products

Is Saks Global Bankruptcy Exposure Reshaping Credit Risk Perceptions For Puig Brands (BME:PUIG)?

Saks Global’s recent Chapter 11 bankruptcy filing revealed that Puig Brands is an unsecured creditor, with about US$12,000,000 in outstanding receivables tied to the luxury retailer’s restructuring of more than €700,000,000 in debt. This exposure highlights Puig’s credit risk to key distribution partners, raising questions about the timing and extent of any recovery despite Saks securing US$1.75 billion in new financing to keep operations running. Against this backdrop, we’ll explore how...